Frontiers in Biosecurity: AI and biosecurity

​Join us for a moderated discussion with leading experts about how AI is reshaping the biorisk landscape, the existing policy and capability gaps, and where philanthropic capital can make a significant impact.

Sandeep Patel, PhD, Host. CEO of Catalyze, an open-science network connecting researchers, funders, and the science-curious. Former Director of BARDA DRIVe at HHS, where he built public-private partnerships and moved >$1B to accelerate pandemic-preparedness technology. PhD scientist turned operator focused on how capital moves into research.

Matthew Hepburn, MD, Panelist. Chief Medical Officer at Avinora Health and one of the most experienced operators in U.S. pandemic preparedness. Played a key role in vaccine development for Operation Warp Speed, served as the inaugural director of pandemic prevention at the White House Office of Science and Technology Policy, and ran several biodefense programs at DARPA as a program manager. Physician and retired Army infectious disease specialist.

​Tom Inglesby, MD, Panelist. Director of the Johns Hopkins Center for Health Security, one of the most influential biosecurity research centers in the world. A leading voice on the intersection of AI and biology, his team's work on biosecurity guardrails for frontier AI models, AI-enabled biological design tools, and dual-use research policy has shaped how governments, industry, and AI labs think about converging biorisks. Adviser to multiple U.S. administrations on pandemic and biological-threat policy, including service as senior policy advisor on the White House COVID-19 Response Team, and a practicing infectious disease physician.

​Christine Parthemore, Panelist. Former CEO of the Council on Strategic Risks (CSR), where she led work at the intersection of biosecurity, AI, and emerging-technology policy and runs the Janne E. Nolan Center on Strategic Weapons. Previously Senior Advisor at the U.S. Department of Defense and a long-standing voice on how converging biological, technological, and geopolitical risks should shape U.S. defense and preparedness investments. Frequent contributor to congressional, executive-branch, and international discussions on biorisk and weapons-of-mass-destruction policy.